Edwin Jonathan Tucker
CIK 1792296 · View on SEC EDGAR ↗
First SEC filing: Oct. 28, 2019 · Latest: Oct. 28, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2021 | MIRM | S | 1,364 | $19.26 | $26,271 | 45,768 Direct | -2.89% | Disposed | 432.3% (price as of 2026-08-19) |
| March 20, 2020 | MIRM | P | 2,500 | $11.90 | $29,750 | 6,000 Direct | +71.43% | Acquired | 761.5% (price as of 2026-08-19) |
| March 19, 2020 | MIRM | P | 2,000 | $9.91 | $19,820 | 3,500 Direct | +133.33% | Acquired | 934.5% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 4, 2025 | JSPRW | Stock Option (right to buy) | Voting Common Stock (90,000) | $6.00 | June 4, 2035 | 90,000 | Acquired |
| Feb. 13, 2025 | JSPRW | Stock Option (right to buy) | Voting Common Stock (50,000) | $6.20 | Feb. 13, 2035 | 50,000 | Acquired |
| Feb. 15, 2024 | JSPRW | Stock Option (right to buy) | Voting Common Stock (45,000) | $17.95 | Feb. 15, 2034 | 45,000 | Acquired |
| June 12, 2023 | JSPRW | Stock Option (right to buy) | Voting Common Stock (400,000) | $1.62 | June 12, 2033 | 400,000 | Acquired |
| March 5, 2021 | MIRM | Stock Option (right to buy) | Common Stock (1,082) | $7.70 | Oct. 23, 2029 | 1,082 | Disposed |
| Jan. 7, 2021 | MIRM | Stock Option (right to buy) | Common Stock (65,000) | $19.19 | Jan. 6, 2031 | 65,000 | Acquired |
| Dec. 28, 2020 | MIRM | Stock Option (right to buy) | Common Stock (4,167) | $7.70 | Oct. 23, 2029 | 4,167 | Disposed |
| Oct. 30, 2020 | MIRM | Stock Option (right to buy) | Common Stock (25,000) | $7.70 | Oct. 23, 2029 | 25,000 | Disposed |
| Jan. 10, 2020 | MIRM | Stock Option (right to buy) | Common Stock (20,000) | $19.24 | Jan. 9, 2030 | 20,000 | Acquired |
| Oct. 24, 2019 | MIRM | Stock Option (right to buy) | Common Stock (100,000) | $7.70 | Oct. 23, 2029 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 28, 2019 | MIRM | Common Stock | 1,500 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MIRM
Chief Medical Officer(8)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $383,075 | — | $207,919 | $946,010 | — | — | $418,717 | $1,955,721 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $312,673 | — | — | $679,549 | — | — | $544,810 | $1,537,032 |
| 2024 | $514,500 | — | — | $689,324 | $196,796 | — | — | $1,400,620 |
| 2023 | $272,955 | $50,000 | — | $544,400 | $110,371 | — | — | $977,726 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.